Skip to content

Randomized Controlled Trial of the Effects of Electroacupuncture Preconditioning in Children Undergoing Cardiac Surgery

National Natural Science Foundation of China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01227096
Enrollment
60
Registered
2010-10-25
Start date
2010-10-31
Completion date
2011-07-31
Last updated
2011-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Defects

Keywords

electroacupuncture pediatric cardioprotection

Brief summary

The purpose of this study is to determine whether electroacupuncture preconditioning would provide protection against myocardial Ischemic-Reperfusion injury and systemic inflammation in children undergoing CPB for repair of congenital heart defects.

Detailed description

2-12 years old children undergoing repair of congenital heart defects were included, except for those with server pulmonary arterial hypertension, chromosomal defects, airway and parenchymal lung disease, immunodeficiency, or blood disorders were excluded. Children were equal randomized to EAPC(electroacupuncture preconditioning)or control group. Electroacupuncture was administered on the bilateral P6 acupoint after anesthesia induction, but prior to surgery in EAPC group. Control patients underwent sham placement of the electrode the arm without stimulation. The duration of cardiopulmonary bypass and aortic cross-clamp time was recorded. Myocardial injury was assessed by cardiac heart-type fatty acid-binding protein (HFAP) and cardiac troponin I (cTnI\>0.40 ng/mL). 8-isoprostane , C-reactive protein, cytokines were measured pre- and postoperatively.

Interventions

electroacupuncture would be administered on the bilateral P6 acupoint after anesthesia induction, but prior to surgery.

Sponsors

National Natural Science Foundation of China
CollaboratorOTHER_GOV
Air Force Military Medical University, China
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Aged 2-12 years children undergoing repair of congenital heart defects without server pulmonary arterial hypertension or systematic disease. * Get an informed consent from parental.

Exclusion criteria

* Patient's age is less than 2 years or more than 12 years. * Patient with isolated atrial septal defect undergoing repair via thoracoscope completion. * Patients with chromosomal defects, airway and parenchymal lung disease, immunodeficiency, or blood disorders. * Patients without an informed consent from parental.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026